Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07458386

Complementary & Integrative Healthcare for Children With Autism: A Pilot Study

To investigate the feasibility of implementing an online assessment battery in tandem with normal & customary complementary & integrative healthcare (CIH) provided to children with autism. The secondary aim is to assess the potential impacts of CIH on clinical outcomes.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

3 year–12 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Brain Development, Biddenden, United Kingdom

Loading trial locations.

About this study

The main aim of this pilot observational study is to investigate the feasibility of implementing an online assessment battery in tandem with normal & customary, fee-for-service, remotely delivered complementary & integrative healthcare (CIH, i.e., naturopathy + functional neurological rehabilitation) provided to children with significant parent-reported autism spectrum disorder (ASD)-related symptoms. The primary outcomes are 1) eligibility, 2) compliance, 3) adherence, and 4) retention. A secondary/exploratory aim is to assess the potential clinical impacts of CIH via a validated parent-reported outcome measure (i.e., Autism Treatment & Evaluation Checklist; ATEC). Data from this study will inform the feasibility of a definitive study powered to assess the effectiveness of CIH care on clinical outcomes in a pediatric population with ASD-related symptoms.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 3-12 years of age
  • Baseline ATEC score >71

Exclusion criteria

  • History of epilepsy

Treatment and study plan

Primary outcomes

  1. Proportion of enrollees who are eligible to participate

    Time frame: From enrollment to baseline ATEC submission (up to 48-hours).

    The number of enrollees (i.e., participants who consent) who score >71 on the baseline Autism Treatment & Evaluation Checklist (ATEC), divided by the total number of enrollees. This assesses 'Eligibility'.

  2. Proportion of participants complying with instructions

    Time frame: From enrollment to the end of participation (up to 6-months)

    The number of participants submitting all online ATECs within the 48-hour submission window, divided by the total number of participants. This assesses 'Compliance'.

  3. Proportion of participants adhering to recommendations

    Time frame: From enrollment to the end of participation (up to 6-months)

    The number of participants attending ≥90% of scheduled online check-ins with the CIH practitioners, divided by the total number of participants. This assesses 'Adherence'.

  4. Proportion of participants retained in the study

    Time frame: From enrollment to the end of the 6-month study period

    The number of participants submitting the 5th and final ATEC, divided by the total number of participants. This assesses 'Retention'.

Secondary outcomes

  1. Change in ATEC scores

    Time frame: Baseline; ~1 month; ~3 months; ~4 months; ~6 months

    Change in ATEC scores from baseline. The ATEC is a 77-item parent-report questionnaire encompassing four distinct domains (i.e., speech/language, sociability, sensory/cognitive awareness, & health/physical/behavior) designed to track the progress of individuals with ASD-related symptoms. Total scores on the ATEC range from 0 to 179 with higher scores indicating greater severity of symptoms.

Sponsors and collaborators

Lead sponsor

Life University

Other

Registry information

Official study title

A Complementary and Integrative Healthcare (CIH) Model for Children With Autism Spectrum Disorder-Related Symptoms: A Pilot Observational Study

Acronym: UNK

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 9, 2026
Registry last updated
Mar 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.